Micro Medical Solutions today said it has received FDA breakthrough device designation for its MicroStent vascular stent.
The stent is designed to maintain vessel patency, enhance wound treatment and improve quality of life and blood flow to reduce amputations and mortality for patients with critical limb-threatening ischemia (CLTI) from peripheral artery disease.